寻找成人心脏手术中肝素抵抗的统一定义:ISTH SSC围术期与危重症血栓与止血分委会通讯
该通讯由ISTH SSC围术期与危重症血栓与止血分委会发布,针对成人心脏手术体外循环(CPB)中肝素抵抗缺乏统一定义的问题,回顾临床试验与报告,评估现有定义差异并分析基于ACT目标值和普通肝素剂量变异导致的报告发生率差异。结果显示,CPB最广泛报告的ACT目标为≥480秒,多数文献将肝素抵抗定义为按体重给予400 U/kg或500 U/kg肝素后未达到该目标。作者提出将500 U/kg肝素后无法达到ACT≥480秒作为标准化定义,以指导未来临床试验和临床管理。
要点
- ISTH SSC建议将成人心脏手术CPB中肝素抵抗标准化定义为:给予500 U/kg普通肝素后仍无法达到ACT≥480秒。
- CPB最广泛报告的ACT目标为≥480秒。
- 多数文献将肝素抵抗定义为按体重给予400 U/kg或500 U/kg肝素后未达到ACT目标。
- 现有肝素抵抗定义不统一,导致报告发生率存在差异。
- 标准化定义旨在指导未来临床试验并改善临床管理。
适用人群与场景
- 需要心脏手术和体外循环(CPB)的成人患者。
诊断标准与关键阈值
- 肝素抵抗的标准化定义(ISTH SSC建议):给予500 U/kg普通肝素后仍无法达到CPB的ACT目标≥480秒。
- CPB最广泛报告的ACT目标为≥480秒。
- 多数文献将肝素抵抗定义为按体重给予400 U/kg或500 U/kg肝素后未达到ACT目标。
研究设计与关键结果
- 该通讯回顾临床试验和报告,评估成人心脏手术CPB中使用的各种肝素抵抗定义,并分析基于ACT目标值和普通肝素剂量变异导致的报告发生率差异。
- 最广泛报告的CPB ACT目标为≥480秒。
- 多数出版物将肝素抵抗定义为按体重给予400 U/kg或500 U/kg肝素后未达到ACT目标。
- 作者提出将500 U/kg肝素后无法达到ACT≥480秒作为肝素抵抗的标准化定义。
证据类型、等级与局限
- 证据类型:ISTH SSC分委会通讯(综述与专家共识)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者建议将成人心脏手术CPB中肝素抵抗标准化定义为:给予500 U/kg普通肝素后仍无法达到ACT≥480秒,以指导未来临床试验并帮助改善临床管理。
指南或共识出处
- ISTH SSC围术期与危重症血栓与止血分委会通讯,发表于J Thromb Haemost。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Ensuring adequate anticoagulation for patients requiring cardiac surgery and cardiopulmonary bypass (CPB) is important due to the adverse consequences of inadequate anticoagulation with respect to bleeding and thrombosis. When target anticoagulation is not achieved with typical doses, the term heparin resistance is routinely used despite the lack of uniform diagnostic criteria. Prior reports and guidance documents that define heparin resistance in patients requiring CPB and guidance documents remain variable based on the lack of standardized criteria. As a result, we conducted a review of clinical trials and reports to evaluate the various heparin resistance definitions employed in this clinical setting and to identify potential standards for future clinical trials and clinical management. In addition, we also aimed to characterize the differences in the reported incidence of heparin resistance in the adult cardiac surgical literature based on the variability of both target-activated clotting (ACT) values and unfractionated heparin doses. Our findings suggest that the most extensively reported ACT target for CPB is 480 seconds or higher. Although most publications define heparin resistance as a failure to achieve this target after a weight-based dose of either 400 U/kg or 500 U/kg of heparin, a standardized definition would be useful to guide future clinical trials and help improve clinical management. We propose the inability to obtain an ACT target for CPB of 480 seconds or more after 500 U/kg as a standardized definition for heparin resistance in this setting.
参考来源
- Levy JH, Sniecinski RM, Maier CL, et al. Finding a common definition of heparin resistance in adult cardiac surgery: communication from the ISTH SSC subcommittee on perioperative and critical care thrombosis and hemostasis. J Thromb Haemost. 2024. PMID: 38215912. doi:10.1016/j.jtha.2024.01.001
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。